HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between rewarming duration and neurological outcome in out-of-hospital cardiac arrest patients receiving therapeutic hypothermia.

AbstractAIM:
The European Resuscitation Council guidelines recommend a slow rate of rewarming of 0.25 °C/h-0.5 °C/h for out-of-hospital cardiac arrest (OHCA) patients receiving therapeutic hypothermia (TH). Conversely, a very slow rewarming of 1 °C/day is generally applied in Japan. The rewarming duration ranged from less than 24 h up to more than 50 h. No randomized control trials have examined the optimal rewarming speed for TH in OHCA patients. Therefore, we examined the association between the rewarming duration and neurological outcomes in OHCA patients who received TH.
METHODS:
This study was a secondary analysis of the Japanese Population-based Utstein-style study with defibrillation and basic/advanced Life Support Education and implementation-Hypothermia (J-PULSE-HYPO) study registry, a multicenter prospective cohort study. Patients suffering from OHCA who received TH (target temperature, 34 °C) after the return of spontaneous circulation from 2005 to 2011 in 14 hospitals throughout Japan were enrolled. The rewarming duration was defined as the time from the beginning of rewarming at a target temperature of 34 °C until reaching 36 °C. The primary outcome was an unfavorable neurological outcome at hospital discharge, i.e., a cerebral performance category of 3-5.
RESULTS:
The J-PULSE-HYPO study enrolled 452 OHCA patients. Of these, 328 were analyzed; 79.9% survived to hospital discharge, of which 56.4% had a favorable neurological outcome. Multivariable logistic regression analysis revealed that the rewarming duration was independently associated with unfavorable neurological outcomes [odds ratio (per 5 h), 0.89; 95% confidence interval, 0.79-0.99; p =  0.032].
CONCLUSION:
A longer rewarming duration was significantly associated with and was an independent predictor of favorable neurological outcomes in OHCA patients who received TH.
AuthorsToru Hifumi, Akihiko Inoue, Nobuaki Kokubu, Mamoru Hase, Naohiro Yonemoto, Yasuhiro Kuroda, Kenya Kawakita, Hirotaka Sawano, Yoshio Tahara, Kenji Nishioka, Shinichi Shirai, Hiroshi Hazui, Hideki Arimoto, Kazunori Kashiwase, Shunji Kasaoka, Tomokazu Motomura, Yuji Yasuga, Hiroyuki Yokoyama, Ken Nagao, Hiroshi Nonogi, J-PULSE-Hypo Investigators
JournalResuscitation (Resuscitation) Vol. 146 Pg. 170-177 (01 01 2020) ISSN: 1873-1570 [Electronic] Ireland
PMID31394154 (Publication Type: Journal Article)
CopyrightCopyright © 2019 Elsevier B.V. All rights reserved.
Topics
  • Cardiopulmonary Resuscitation (adverse effects, methods)
  • Duration of Therapy
  • Female
  • Humans
  • Hypothermia, Induced (methods)
  • Japan (epidemiology)
  • Male
  • Middle Aged
  • Nervous System Diseases (epidemiology, etiology, prevention & control)
  • Neuroprotection
  • Out-of-Hospital Cardiac Arrest (mortality, therapy)
  • Registries (statistics & numerical data)
  • Return of Spontaneous Circulation (physiology)
  • Rewarming (adverse effects, methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: